Infection and Drug Resistance · 2022 · 10 citations · 17 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationInfectious Disease EpidemiologyVaccinologyAdverse Events Following ImmunizationVaccinationVaccine SafetyCd8 Positive T Cell ResponsesCd8 Positive T CellsInfection Risk FactorsRisk Factor EvaluationSars-cov-2 InfectionSars-cov-2 Pneumonia
Objective: Analyzing the risk factors for pneumonia development in breakthrough cases with a history of inactivated vaccine injection is important. The present study aimed to investigate the risk factors for pneumonia development during Omicron variant infection. Design and Methods: The clinical data were retrospectively collected from 187 patients who previously received inactivated vaccine and were infected by the Omicron variant. Results: Among the 187 patients, 73 had 2 doses of inactivated vaccine injection and the remaining 114 had 3 doses; 19 patients had pneumonia at admission. The univariate logistic analysis showed that age, baseline platelet count, D-dimer level, and CD8 + T lymphocyte count were associated with pneumonia development at admission. The multivariate analysis showed that only age was the independent risk factor for pneumonia development (odds ratio = 1.046, 95% confidence interval: 1.003– 1.091, P = 0.04). With an optimal cutoff value of 46, 4.4% (4/91) patients in the age < 46 years group and 15.63% (15/96) patients in the age ≥ 46 years group had pneumonia ( χ 2 = 6.454, P = 0.01). Moreover, age negatively correlated with CD8 + T cell count, B cell count, and albumin and uric acid levels (all P < 0.01), while age positively correlated with the glucose level ( P < 0.01). Conclusion: Old age was the only independent risk factor for pneumonia development in patients with Omicron variant infection and a history of inactivated vaccine injection. Keywords: COVID-19, glucose, Omicron, pneumonia, SARS-CoV-2
17
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Delphine Planas, Nell Saunders, Piet Maes et al. · Nature · 2021 · 1.6K citations · Full text
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
Sho Iketani, Lihong Liu, Yicheng Guo et al. · Nature · 2022 · 857 citations · Full text
Fareed Abdullah, Jonathan E. Myers, Debashis Basu et al. · International Journal of Infectious Diseases · 2021 · 437 citations · Full text
Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +12
Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages
Jingwen Ai, Xun Wang, Xinyi He et al. · Cell Host & Microbe · 2022 · 197 citations · Full text